Molecular design of potential anti-tumor drug candidates via NF-κB pathway gene inhibition
College
College of Science
Department/Unit
Physics
Document Type
Article
Source Title
Journal of Computational Methods in Molecular Design
Volume
3
Issue
1
First Page
9
Last Page
14
Publication Date
2013
Abstract
Advancements in technology have provided many answers for creating new compounds and improving existing ones. It has also allowed researchers to create drug lead molecules according to their preferences. Through this, trial and error method in drug design has been reduced. Furthermore, drug design is now less time consuming and cost-efficient with the use of computer aided drug design (CADD). In this study, CADD is used to create IKK and p50 inhibitor candidates deemed to possess better specifically and potency in targeting the NF-kB gene. The candidate inhibitors were designed utilizing ligand based drug design techniques in compliance with established confidence levels of their relevant chemical descriptors. The theoretical candidate inhibitors that were designed showed a high degree of possibility to be an anti-inflammatory drug and consequently, as anti-tumor agents.
html
Recommended Citation
Nonato, M., Inoue, R., Janairo, J. B., Janairo, G. C., & Yu, D. C. (2013). Molecular design of potential anti-tumor drug candidates via NF-κB pathway gene inhibition. Journal of Computational Methods in Molecular Design, 3 (1), 9-14. Retrieved from https://animorepository.dlsu.edu.ph/faculty_research/6600
Disciplines
Medicinal Chemistry and Pharmaceutics
Keywords
Antineoplastic agents—Design
Upload File
wf_no